CTI BioPharma Investor
CTI BioPharma is a biopharmaceutical company developing oncology products for the treatment of cancer.
Industry:
Biotechnology
Headquarters:
Seattle, Washington, United States
Founded Date:
1991
Investor Type:
For Profit
Estimated Revenue:
$1M to $10M
Register and Claim Ownership